A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
A Rare Case of a Patient with Systemic Lupus Erythematosus who Presented with Rowell Syndrome Responding to Treatment with Hydroxychloroquine and Prednisone with One Year of Relapse Free Survival on Belimumab
2021
Modern Rheumatology Case Reports
Preserved Fulltext
Rowell Syndrome, first described in 1963 by Rowell et al., is an infrequently reported and unique syndrome occurring in patients with Systemic Lupus Erythematosus (SLE). This syndrome characteristically presents with erythema multiforme-like lesions as well as other specific immunologic and histopathologic manifestations. Since Rowell's original description, diagnostic criteria have been proposed and modified to better describe the syndrome. We describe a 32-year-old African American female
doi:10.1093/mrcr/rxab013
pmid:34491356
fatcat:5hb4brh5sbbmnj463uze5ofzby